(Q34134664)

English

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Atrial Fibrillation

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

John W. Eikelboom

object named as

John Eikelboom

9

0 references

1

object named as

Lars Wallentin

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

2

object named as

Salim Yusuf

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

11

object named as

Janice Pogue

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

10

object named as

Jonas Oldgren

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Michael D. Ezekowitz

3

object named as

Michael D Ezekowitz

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Muredach P. Reilly

12

object named as

Paul A Reilly

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

4

object named as

Marco Alings

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Maria Grazia Franzosi

6

object named as

Maria Grazia Franzosi

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

7

object named as

Prem Pais

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

13

object named as

Sean Yang

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

author name string

Marcus Flather

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Antonio Dans

8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Stuart J Connolly

14

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

RE-LY investigators

15

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

1 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

376

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

9745

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

975-983

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961194-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961194-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961194-4

7 January 2021

based on heuristic

inferred from DOI database lookup

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961194-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961194-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequency of adverse events in patients with poor anticoagulation: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961194-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticoagulation intensity and outcomes among patients prescribed oral anticoagulant therapy: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961194-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Warfarin anticoagulation and outcomes in patients with atrial fibrillation: a systematic review and metaanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961194-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961194-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Worldwide management of oral anticoagulant therapy: the ISAM study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961194-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961194-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961194-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961194-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of study setting on anticoagulation control: a systematic review and metaregression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961194-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticoagulation treatment for the reduction of stroke in atrial fibrillation: a cohort study to examine the gap between guidelines and routine medical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961194-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961194-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2961194-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(10)61194-4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34134664&oldid=2105018967"